BioSpace News Archive

Pharm Country

Gotham Therapeutics and Mercachem Announce Progress in Compound Library Development Tailored for Epitranscriptomic Drug Discovery

Research led to a collection of over 2,000 analogues and over 80 distinct chemotypes displaying an up to 1,000-fold increased affinity to epitranscriptomic targets.

July 17, 2019
·
3 min read
Oblique Therapeutics has been Recognized as one of the 15 Most Promising Biotech Startups in Europe 2019, by StartUp City Magazine

Oblique Therapeutics, a Swedish biotech focusing on generating novel therapeutic antibodies towards severe diseases such as cancer and pain, has been honored as one of the most promising biotech startup in Europe 2019 by StartUp City magazine.

July 17, 2019
·
2 min read
Drug Development

PureTech Acquires New Clinical-Stage Program LYT-100 to Treat Lymphedema

Wholly owned program adds to Company’s growing internal pipeline focused on lymphatic targeting and tissue-selective immunomodulation

July 17, 2019
·
6 min read
BioMidwest

Exact Sciences Designated a Great Place to Work-Certified™ Company in 2019

Hundreds of open positions offer opportunity to join growing company

July 17, 2019
·
7 min read
Business

Catholic Health Services Partners with Quest Diagnostics to Deliver High-Value, Innovative Laboratory Services

Catholic Health Services, an integrated health care delivery system with a 24% market share on Long Island, is teaming up with Quest Diagnostics, the world’s leading provider of diagnostic information services, to enhance the quality and value of diagnostic services to patients and their doctors.

July 17, 2019
·
2 min read
Deals

Bruker Comments on Block Trade Transaction - July 17, 2019

Bruker Corporation has been advised that former board member, Mr. Joerg C. Laukien, has authorized a block sale of Bruker shares as part of his retirement planning and portfolio diversification.

July 17, 2019
·
1 min read
Deals

The Medicines Company to Announce Second Quarter 2019 Financial Results on July 24

The Medicines Company will host a conference call and audio webcast on Wednesday, July 24, 2019 at 8:30 a.m. EDT to discuss its second quarter 2019 financial results and operational developments.

July 17, 2019
·
1 min read
Deals

Getinge Publishes Interim Report for January - June 2019

Getinge is reporting an increase in organic sales by 4.0% and an increased order intake of 5.2% organically, which means that Getinge’s growth remains higher than the market average.

July 17, 2019
·
3 min read
Job Trends

GB Sciences Files Novel Patent Application For Chronic Pain Treatments Based On Proprietary Cannabis-Derived Formulations

In the US, chronic pain represents an estimated health burden of between $560 and $650 billion dollars.

July 17, 2019
·
5 min read
Business

Anixa Biosciences Announces a Strategic Alliance and Licensing Agreement with Cleveland Clinic for an Innovative Breast Cancer Vaccine Technology

Anixa to Host a Conference Call Thursday, July 18, 2019, 4:30 p.m. ET to Discuss Agreement

July 17, 2019
·
4 min read